|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan (K.S., S.O., K.M., Y.I.); and Laboratory of Organic and Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan (T.N., T.O.)
Received for publication
August 4, 2005
Accepted
September 28, 2005.
| Abstract |
|---|
|
|
|---|
or
1) is the site of action for diCl-DHAA. BK channel activity was significantly enhanced by diCl-DHAA at concentrations of 0.1 µM and higher in a concentration-dependent manner. diCl-DHAA enhanced the activity of BK
by increasing sensitivity to both Ca2+ and membrane potential without changing the single channel conductance. It is notable that the increase in BK channel open probability by diCl-DHAA showed significant inverse voltage dependence, i.e., larger potentiation at lower potentials. Since coexpression of
1 subunit with BK
did not affect the potency of diCl-DHAA, the site of action for diCl-DHAA is suggested to be BK
subunit. Moreover, kinetic analysis of single channel currents indicates that diCl-DHAA opens BK
mainly by decreasing the time staying in a long closed state. Although reconstituted voltage-dependent Ca2+ channel current was significantly reduced by 1 µM diCl-DHAA, BK channels were selectively activated at lower concentrations. These results indicate that diCl-DHAA is one of the most potent BK channel openers acting on BK
and a useful prototype compound to develop a novel BK channel opener.
In addition, the negative feedback control of intracellular Ca2+ concentration ([Ca2+]i) by BK channels works to protect cells from Ca2+ overload during pathophysiological conditions (Lawson, 2000
). Hyperpolarization of neuronal cells by BK channel activation down-regulates the activity of voltage-dependent Na+ and Ca2+ channels and may prevent cell death, which is mainly caused by excess intracellular Ca2+ in the setting of brain ischemia following stroke. In smooth muscle cells, BK channels are also activated by spontaneous Ca2+ release from sarcoplasmic reticulum (Nelson and Quayle, 1995
; Bolton and Imaizumi, 1996
; Imaizumi et al., 1999
) and are thought to be one of the essential regulators of resting membrane potential. Accumulated evidence indicates that the control of BK channel activity in arterial smooth muscle is one of the major determinants of vascular tone and that its abnormality can be a cause of hypertension (Brenner et al., 2000b
; Wellman and Nelson, 2003
; Fernández-Fernández et al., 2004
).
Agents that enhance BK channel activity (BK channel openers) may therefore be effective in protecting neurons from damage following an ischemic stroke and/or in suppressing excess activity of smooth muscle tissues (Lawson, 2000
). Many compounds that were found from natural products or were synthesized have been reported to be BK channel openers (Coghlan et al., 2001
). Most of these BK channel openers, including BMS-204352 (Gribkoff et al., 2001
), are not highly potent activators (EC50 values >300 nM) under the resting cellular conditions where intracellular Ca2+ concentration is 50 to 150 nM (Schrøder et al., 2003
). Terpenoids derived from natural products dehydrosoyasaponin-I, maxikdiol, and L-735,334 have been reported as BK channel openers (Kaczorowski and Garcia, 1999
). In addition, 17
-estradiol (Valverde et al., 1999
) and epoxyeicosatrienoic acids (Fukao et al., 2001
) may be endogenous BK channel openers, and some transmitters and hormones can enhance BK channel activity via kinase activation (Vergara et al., 1998
).
In our previous study (Imaizumi et al., 2002
), novel compounds, including pimaric acid, were discovered from terpenoids, which have chemical structures similar to that of maxikdiol, a moderate BK channel opener (Singh et al., 1994
). Moreover, our recent study (Ohwada et al., 2003
) has revealed that chemical modification of abietic acid, an inactive compound of resin acid derivatives, to dehydroabietic acid resulted in BK channel opening, and further chemical modification to 12,14-dichlorodehydroabietic acid (diCl-DHAA) led to finding of a potent BK channel opener. However, the underlying mechanisms of diCl-DHAA-induced activation of BK channel and the selectivity against voltage-dependent Ca2+ (CaV) channel have not been defined. The present study was therefore undertaken to identify molecular mechanisms of diCl-DHAA-induced activation of BK channels and to examine the selectivity against inhibition of CaV channels by using human embryonic kidney (HEK) 293 cells as an expression system.
| Materials and Methods |
|---|
|
|
|---|
(KpnI/XbaI-double digested) and BK
1 (EcoRI/XbaI-double digested) were ligated into mammalian expression vectors pcDNA3.1(+) and pcDNA3.1/Zeo(+) (Invitrogen, Carlsbad, CA), respectively, using the TaKaRa ligation kit version 1 (TaKaRa, Osaka, Japan) (Yamada et al., 2001
and BK
was achieved by using calcium phosphate coprecipitation transfection techniques as reported previously (Imaizumi et al., 2002
-expressing and BK
1-coexpressing, respectively.
The cDNAs encoding voltage-dependent Ca2+ channel
1C subunit of the rabbit (rCaV
1C) and
3 subunit of the mouse (mCaV
3) were kind gifts from Dr. Veit Flockerzi (Institut für Pharmakologie und Toxikologie, Universität des Saarlandes, Hamburg, Germany) and were ligated into mammalian expression vectors pcDNA3.1(+) and pTracer(+), respectively (Murakami et al., 2003
). These plasmid vectors were transfected into HEK293 cells for transient expression. The functional coexpression of rCaV
1C and mCaV
3 was successfully determined by the appearance of the inward currents and green fluorescent protein fluorescence.
Solutions. The standard HEPES-buffered solution for electrophysiological recording had an ionic composition of 137 mM NaCl, 5.9 mM KCl, 2.2 mM CaCl2, 1.2 mM MgCl2, 14 mM glucose, and 10 mM HEPES. The pH of the solution was adjusted to 7.4 with NaOH. The pipette solution for whole-cell recordings of K+ currents contained 140 mM KCl, 1 mM MgCl2, 10 mM HEPES, 2 mM Na2ATP, and 5 mM EGTA. The pCa and pH of the pipette solution were adjusted to 6.5 and 7.2 by adding CaCl2 and KOH, respectively. For recordings of single BK channel currents in the excised inside-out patch configuration, the pipette solution contained the standard HEPES-buffered solution or K+-rich HEPES-buffered solution that was prepared by replacement of 134.1 mM NaCl in the standard HEPES-buffered solution with equimolar KCl. The bathing solution contained 140 mM KCl, 1.2 mM MgCl2, 14 mM glucose, 10 mM HEPES, and 5 mM EGTA. Selected pCa of the bathing solution was obtained by adding adequate amount of CaCl2, and the pH was adjusted to 7.2 with NaOH. The pipette solution for whole-cell recording of Ca2+ inward currents had an ionic composition of 140 mM CsCl, 1 mM MgCl2, 10 mM HEPES, 2 mM Na2ATP, and 5 mM EGTA. The pH of the pipette solution was adjusted to 7.2 by adding CsOH.
Electrophysiological Experiments. The whole-cell and insideout patch clamps were applied to single cells using CEZ-2400 amplifier (Nihon Kohden, Tokyo, Japan) and EPC-7 amplifier (List Electronics, Darmstadt, Germany), respectively. The procedures of electrophysiological recordings and data acquisition/analysis for whole-cell recording have been described previously (Imaizumi et al., 1989
). The resistance of the pipette was 1.5 to 3 M
for whole-cell and 15 to 25 M
for inside-out patch configurations when filled with the pipette solutions. The series resistance was partly compensated electrically under whole-cell voltage clamp. Whole-cell and single channel recordings were carried out at room temperature (24 ± 1°C). Single channel current analyses were done using software PAT V7.0C (developed by Dr. J. Dempster, University of Strathclyde, Glasgow, Scotland). The open probability (Po) was measured from the event histogram plotted against current amplitude. The number of channels in a patch was determined from recordings at pCa = 3.5, and the analyses were performed only when the number of channels in a patch was less than six.
Chemicals. Most of pharmacological agents were obtained from Sigma-Aldrich (St. Louis, MO), unless mentioned otherwise. Iberiotoxin was obtained from Peptide Institute Inc. (Osaka, Japan). Pimaric acid, abietic acid, dehydroabietic acid, and diCl-DHAA were obtained from Helix Biotech (New Westminster, BC, Canada). The test compounds were dissolved with dimethyl sulfoxide. The final concentration of dimethyl sulfoxide was 0.03% or lower.
Statistics. Data are expressed as means ± S.E.M. Statistical significance between two groups and among multiple groups was evaluated using Student's t test and Scheffé's test after F-test or one-way analysis of variance, respectively.
| Results |
|---|
|
|
|---|

1 under whole-cell voltage-clamp mode. The Ca2+ concentration in the pipette solution was fixed at pCa = 6.5 using a Ca2+-EGTA buffer (see Materials and Methods). Depolarization from 60 to +10 mV induced outward currents in both native HEK and HEKBK
1, whereas the current density was approximately 4 times larger in the latter cells as reported previously (Imaizumi et al., 2002
1 in a dose-dependent manner (Fig. 1, A and B) but not in native HEK cells (data not shown). The enhancement of the outward currents in HEKBK
1 was completely removed by washout of diCl-DHAA (Fig. 1B). The relationship between concentrations of diCl-DHAA and corresponding responses is summarized in Fig. 1C. The increase in outward current density by diCl-DHAA was significant at a concentration of 0.1 µM and higher. Taking the current density at +10 mV in the control as unity, the relative amplitude of peak outward currents in the presence of 0.1, 0.3, and 1 µM diCl-DHAA was also plotted against concentration (Fig. 1C).
|
|
|

1 was depolarized from a holding potential of 60 mV to test potentials in the range between 50 and +30 mV with 10-mV steps (Fig. 2A). Application of 1 µM diCl-DHAA increased the currents at any test potential. Addition of 100 nM iberiotoxin, a specific BK channel blocker, removed the enhancement of outward currents, supporting that the action of diCl-DHAA was selective to BK channel currents. Figure 2B summarizes the relationships between current density of peak outward currents and test potentials in the absence and presence of 1 µM diCl-DHAA and after addition of 100 nM iberiotoxin. The current density at +30 mV was increased from 39.13 ± 7.34 to 142.55 ± 30.81 pA/pF (n = 7; p < 0.01). In Fig. 2C, the voltage dependence of diCl-DHAA-induced enhancement of BK channel currents was determined as the relationship between the relative potentiation of outward currents and test potentials by taking the potentiation at +30 mV in the presence of 1 µM diCl-DHAA as unity. The potentiation at 20 and 10 mV was significantly greater than that at +30 mV (4.48 ± 1.15 and 3.80 ± 1.09 times at 20 and 10 mV, respectively, p < 0.01, versus unity at +30 mV).
|
Channel Current by diCl-DHAA and Related Compounds. Effects of diCl-DHAA on single BK
channel currents were examined in excised inside-out patch configuration. The bathing and pipette solution contained symmetrical 140 mM K+. The free Ca2+ concentration in the bathing solution was pCa7. Under these conditions, the unitary current amplitude and open probability (Po) at +40 mV was 10.1 ± 0.2 pA and 0.0028 ± 0.0005 (n = 6), respectively. The application of 1 µM diCl-DHAA increased channel activity without change in the unitary current amplitude (10.43 ± 0.28 pA, 0.0180 ± 0.0047, n = 6; Fig. 3, A and B). It is notable that diCl-DHAA was effective on BK
even when applied to the cytosolic phase. This effect of diCl-DHAA was completely removed by the washout. The Po was significantly increased by diCl-DHAA at 0.3 µM and higher concentrations (Fig. 3C), and the relative Po determined by taking Po in the control as unity was 1.26 ± 0.13, 1.92 ± 0.19, 6.24 ± 0.67, and 14.45 ± 1.72 in the presence of 0.1, 0.3, 1.0, and 3.0 µM diCl-DHAA, respectively (n = 46). These results are mostly comparable with those obtained under whole-cell clamp conditions (Fig. 1C). In Fig. 4, the potency of diCl-DHAA to activate BK
was compared with that of abietic acid and dehydroabietic acid, an aromatic derivative of abietic acid. The data for pimaric acid, a potent BK channel opener, were also taken from a previous study, where the potency of pimaric acid was determined under the same experimental conditions (Imaizumi et al., 2002
, whereas dehydroabietic acid at 3 and 10 µM increased activity significantly. Nevertheless, diCl-DHAA was much more potent as an activator of BK
than dehydroabietic acid and pimaric acid.
|
Channel Currents. In Fig. 5, effects of diCl-DHAA on characteristics of single BK
channel currents were systematically examined in the excised inside-out patch configuration. The bathing and pipette solution contained symmetrical 140 mM K+. The pCa in the bathing solution was 7. The conductance of BK
, which was determined by slope of the regression line between 0 and +70 mV, was 224.8 ± 4.1 and 224.8 ± 4.3 pS in the absence and presence of 10 µM diCl-DHAA, respectively (n = 6; p > 0.05; Fig. 5B), indicating that diCl-DHAA did not affect BK
channel conductance. The inward rectification shown at high potentials (more than +80 mV) was consistent with that reported as voltage-dependent block of BK channel by Na+ (Yellen, 1984
![]() | (1) |
In Fig. 6, the effects of diCl-DHAA on Ca2+ sensitivity of BK
were examined at 0 mV in asymmetrical 5.9/140 mM K+ conditions. When Ca2+ concentration in the bathing solution was elevated in a pCa range between 7.0 and 5.0, the Po was increased in a concentration-dependent manner (Fig. 6, A and B). The relationship between Ca2+ concentration and the Po of BK
was fitted by the following equation:
![]() | (2) |
subunit in the tetrameric complex of a functional BK
channel, was not significantly affected (3.83 ± 0.45; p > 0.05 versus control). C was 0.102 ± 0.008 and not affected by diCl-DHAA (p > 0.05 versus control). The relative Po in the presence of 10 µM diCl-DHAA to that of the control was plotted against [Ca2+]i in Fig. 6C. The lower the Po in the control conditions, the larger the enhancement by diCl-DHAA.
|
Effects of diCl-DHAA on the kinetic properties of BK
were examined in excised inside-out patches, which included only one channel (Fig. 7). These patches had a single channel event even when [Ca2+]i was elevated to pCa = 3.5. Figure 7A shows original current traces of BK
at pCa = 6.5 in the absence and presence of 10 µM diCl-DHAA. The data for open and closed dwell time in Fig. 7A were reconstituted as distribution histograms in Fig. 7, B and C, respectively. These histograms were well fitted by a double and triple exponential function, respectively (Fig. 7, B and C). As shown in Table 1, application of 10 µM diCl-DHAA caused a marked decrease in the mean closed time (
Cs) and its relative magnitude (ACs) of the slow component (45 times change), whereas other parameters were moderately changed (
Os,
Cf,
Ci, and AOf) or were not affected (
Of, AOs, ACf,, and ACi) (n = 5).
|
|
Comparison of diCl-DHAA-Induced Effects on BK
with Those on BK
1. The enhancement of single BK
channel activity by diCl-DHAA indicated the direct action of this compound on BK
. It has been, however, established that coexpression of
1 subunit with BK
increases the sensitivity of BK
to Ca2+ and voltage (Wallner et al., 1996
; Cox and Aldrich, 2000
). To determine whether diCl-DHAA also acts on the functional coupling between BK
and
1 subunits, the increase in Po by diCl-DHAA in BK
1 was compared with that in BK
in inside-out patches. The Po of BK
at pCa = 7.0 was increased at any test potential by coexpression with
1 subunit (Fig. 8A). Since the increase in Po by diCl-DHAA depended on a basal Po before application (Fig. 6C), effects of diCl-DHAA on BK
at +40 mV were compared with those on BK
1 at +20 mV. The basal Po values were comparable with each other (0.0028 ± 0.0006 versus 0.0023 ± 0.0006; n = 5; Fig. 8B). The application of 1 µM diCl-DHAA increased the Po to 0.0180 ± 0.0058 in BK
(n = 5; p < 0.05) and to 0.0208 ± 0.0037 in BK
1 (n = 5; p < 0.01). The ratio of Po in BK
in the presence and absence of diCl-DHAA was 7.2 ± 0.8 and therefore not significantly different from that in BK
1 (11.1 ± 3.1; p > 0.05). This finding strongly suggests that coexpression of
1 subunit did not affect the diCl-DHAA-induced enhancement of BK
.
|
Selectivity of diCl-DHAA on BK Channel Versus Voltage-Dependent Ca2+ Channel. To examine whether the action of diCl-DHAA is selective to BK channels over CaV channels, effects of 0.3 and 1 µM diCl-DHAA on BK
were compared with those on CaV channel currents in HEK293 cells, which coexpressed
1 subunit of rabbit CaV channel and
3 subunit of mouse CaV
1C
3. Here, effects of pimaric acid on CaV
1C
3 were also examined. The inward currents through CaV
1C
3 were elicited upon depolarization from a holding potential of 60 mV to test potentials in a range of 50 and +40 mV by 10-mV step every 10 s. The maximum amplitude was obtained at +10 mV (peak amplitude, 193 ± 54.4 pA; n = 6; Fig. 9A). CaV
1C
3 channel currents were not inhibited by 0.3 µM diCl-DHAA or pimaric acid, whereas they were significantly inhibited by both compounds at 1 µM (only diCl-DHAA; Fig. 9A). Data about effects of diCl-DHAA and pimaric acid on BK
are those shown in Fig. 3 and provided in a previous study (Imaizumi et al., 2002
) and were obtained in inside-out patches at +40 mV and pCa = 7.0 under symmetrical 140 mM K+ conditions. Enhancement of BK channel activity by diCl-DHAA was significant at 0.3 and 1 µM, indicating that 0.3 µM diCl-DHAA is selective for the BK channel over the CaV channel.
|
| Discussion |
|---|
|
|
|---|
subunit via changing the voltage and Ca2+ sensitivity of the channel. Chemical modification of abietic acid, an inactive compound, to dehydroabietic acid and diCl-DHAA provides a potent and selective BK channel opener. The latter has an inverse voltage dependence for BK
channel activation and is one of the most potent openers available by application from outside of the cell membrane.
BK channels consist of channel-forming
subunits and accessory
subunits (
1
4) arranged in tetramers (Vergara et al., 1998
). Each
subunit interacts with N-terminal region of an
subunit (Wallner et al., 1996
) and regulates the activity of the
subunit by changing Ca2+ and voltage sensitivity and/or channel kinetics. Although only one major type of
subunit with splice variants has been defined, the combination of the BK channel
subunit encoded by KC-NMA1 and
subunits encoded by KCNMB1-4 provides the diversity of BK channels (McManus et al., 1995
; Brenner et al., 2000a
; Uebele et al., 2000
), which offers opportunities of development of new therapeutic agents. Benzimidazolone derivatives such as biarylureas (NS-1608), NS-1619, BMS-204352 (Gribkoff et al., 2001
), arylpyrrole (NS-8), and indole-3-carboxylic acid esters (CGS-7181 and CGS-7184) have been characterized as effective BK channel openers (Coghlan et al., 2001
).
Natural products have also been evaluated as BK channel openers, and terpenoids such as dehydrosoyasaponin I (McManus et al., 1993
), maxikdiol (Singh et al., 1994
), and L-735,334 (Lee et al., 1995
) have been identified as active BK channel openers. Our pioneer work of pimarane compounds, which have a close structural similarity to maxikdiol, has revealed that pimaric acid is a potent BK channel opener that interacts with BK
subunit but not with the BK
1 subunit (Imaizumi et al., 2002
). Pimaric acid activates BK channels in HEKBK
1 when applied externally as well as when applied to the "internal phase" in inside-out patches. Its potency seems to be slightly higher than that of maxikdiol. An important comparative result in the previous study is that abietic acid did not show BK channel opening action despite of the fact that abietic acid is a structural isomer (C20H30O2) of pimaric acid.
Of importance is our recent finding that chemical modification of abietic acid to dehydroabietic acid as well as diCl-DHAA produced compounds active to the open BK channel (Ohwada et al., 2003
). In the present study, we provided new information about mechanisms of diCl-DHAA-induced activation of BK channels. diCl-DHAA activated BK channels in HEKBK
when applied externally as well as when applied to the internal phase in inside-out patches. Its potency was obviously higher than that of pimaric acid in whole-cell recording under the same experimental conditions, since significant activation was observed at 0.1 µM diCl-DHAA (Imaizumi et al., 2002
). Dehydrosoyasaponin-I (Giangiacomo et al., 1998
), 17
-estradiol (Valverde et al., 1999
), and tamoxifen (Dick et al., 2001
) interact with
subunits of BK channels to increase the channel activity. In contrast, NS-1619 (Ahring et al., 1997
), epoxyeicosatrienoic acid (Fukao et al., 2001
), Evans blue (Yamada et al., 2001
), and pimaric acid (Imaizumi et al., 2002
) act on the BK
subunit. Our results clearly showed that diCl-DHAA interacts with the BK
subunit but may not interact with the BK
1 subunit. We also found that 100 nM iberiotoxin completely removed the diCl-DHAA-induced potentiation of the macroscopic BK
1 channel currents. This finding suggests that diCl-DHAA does not affect the iberiotoxin binding to BK
1, although effects of diCl-DHAA on 125I-iberiotoxin binding were not examined in this study. Consistently, the concentration-response relationship of charybdtoxin for the inhibition of macroscopic BK
1 channel currents was not affected by the presence of 10 µM pimaric acid, which has a close structural analogy to diCl-DHAA (Imaizumi et al., 2002
).
It is obvious from the present results that diCl-DHAA activates BK channels in a voltage- and Ca2+-dependent manner. It is very notable that the potentiation of BK channel activity by diCl-DHAA was significantly larger at negative potentials as well as at lower Ca2+ concentrations. In contrast, BMS-204352, a potent BK channel opener, caused activation of BK channel currents only at positive potentials (more than +30 mV; Gribkoff et al., 2001
; Schrøder et al., 2003
). To our knowledge, diCl-DHAA, and presumably pimaric acid as well, are the only compounds that show marked inversed voltage dependence for potentiation among various types of BK channel openers. This characteristic feature of diCl-DHAA can be considered particularly effective to prevent membrane depolarization, hyperexcitability, and/or excess Ca2+ influx to the cell and may be advantageous for clinical use. Moreover, diCl-DHAA decreased the time for the channels to stay in the prolonged closed states. It can be, therefore, suggested that this kinetic change in the presence of diCl-DHAA causes activation of BK channel. Niflumic acid opens BK channels mainly by decreasing the time in the long-closed states (Ottolia and Toro, 1994
).
It is important to characterize the selectivity of diCl-DHAA to BK channels over that of other ion channels. We found that diCl-DHAA at concentrations of 0.3 µM or less increased BK channel activity without inhibiting CaV channels. Moreover, even though diCl-DHAA-induced inhibition of CaV channels at 1 µM was comparable with that by 1 µM pimaric acid (
30% of the control), the activation of BK channel currents by diCl-DHAA was significantly greater than that by pimaric acid, suggesting that the potent activation of BK channels by diCl-DHAA provides more selectivity against CaV channels than that by pimaric acid. The selectivity of BK channel openers against CaV channels has not been well defined, but nordihydroguaiaretic acid or NS-1619-induced inhibition of CaV channel currents was comparable with or slightly more potent than the activation of BK channels, respectively (Holland et al., 1996
; Yamamura et al., 1999
). For development of potent and selective BK channel openers, scaffoldings of dehydroabietic acid may be useful (Ohwada et al., 2003
).
Effects of diCl-DHAA on small (SK) and intermediate (IK) conductance Ca2+-activated K+ channels were not examined systematically in this study. BK channel openers reported so far, including pimaric acid, are however selective over SK and IK channels (Kaczorowski and Garcia, 1999
; Coghlan et al., 2001
; Imaizumi et al., 2002
), and our preliminary data suggest that 1 µM diCl-DHAA did not affect the activities of SK2 and SK4 channels (K. Sakamoto, unpublished data). Genetically, and even functionally in some aspects, KCNMA (BK) is closer to voltage-dependent K+ channels than KCNN (SK and IK), because of the presence of its voltage-sensitive domain (Vergara et al., 1998
). It is therefore worth examining the effects of diCl-DHAA on cloned voltage-dependent K+ channels, which remain to be determined.
In conclusion, our results provide new information of mechanisms underlying diCl-DHAA-induced activation of BK channels and the selectivity against CaV channels. diCl-DHAA is effective from either side of cell membrane and acts on BK
subunit to increase Ca2+ and voltage sensitivity. In contrast to many other BK channel openers, the effect of diCl-DHAA on BK
significantly showed inverse voltage dependence, i.e., larger potentiation at lower membrane potentials. In this respect, diCl-DHAA may be one of the most potent BK channel openers ever known to sensitize the negative feedback control of [Ca2+]i regulation via activation of BK channels, which suppress depolarization from resting membrane potential, and subsequently, membrane excitability. diCl-DHAA at low concentrations (<1 µM) shows selectivity to the BK channel over CaV channels and possesses higher selectivity to BK channels than pimaric acid. Dehydroabietic acid, including diCl-DHAA, is a new prototype scaffolding as a potent BK
channel opener.
| Acknowledgements |
|---|
| Footnotes |
|---|
ABBREVIATIONS: BK, large conductance Ca2+-activated K+; [Ca2+]i, intracellular Ca2+ concentration; BMS-204352, (3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indole-2-one; L-735,334, 14-hedroxy 8-daucene-3,4-diol oleate; diCl-DHAA, 12,14-dichlorodehydroabietic acid; CaV, voltage-dependent Ca2+; HEK, human embryonic kidney; I-V, current-voltage; SK, small conductance Ca2+-activated K+; IK, intermediate conductance Ca2+-activated K+; CGS-7181, ethyl 2-hydroxy-1-[[(4-methylphenyl)amino]oxo]-6-trifluoromethyl-1H-indole-3-carboxylate; CGS-7184, ethyl 1-[[(4-chlorophenyl)amino]oxo]-2-hydroxy-6-trifluoromethyl-1H-indole-3-carboxylate; NS-1608, N-(3-(trifluoromethyl)phenyl)-N'-(2-hydroxy-5-chlorophenyl)urea; NS-1619, 1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one; NS-8, 2-amino-3-cyano-5-(2-fluorophenyl)-4-methylpyrrole.
Address correspondence to: Dr. Yuji Imaizumi, Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabedori, Mizuhoku, Nagoya 467-8603, Japan. E-mail: yimaizum{at}phar.nagoya-cu.ac.jp
| References |
|---|
|
|
|---|
Ahring PK, Strobaek D, Christophersen P, Olesen SP, and Johansen TE (1997) Stable expression of the human large-conductance Ca2+-activated K+ channel
- and
-subunits in HEK293 cells. FEBS Lett 415: 6770.[CrossRef][Medline]
Bolton TB and Imaizumi Y (1996) Spontaneous transient outward currents in smooth muscle cells. Cell Calcium 20: 141152.[CrossRef][Medline]
Brenner R, Jegla TJ, Wickenden A, Liu Y, and Aldrich RW (2000a) Cloning and functional characterization of novel large conductance calcium-activated potassium channel
subunits, hKCNMB3 and hKCNMB4. J Biol Chem 275: 64536461.
Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, and Aldrich RW (2000b) Vasoregulation by the
1 subunit of the calcium-activated potassium channel. Nature (Lond) 407: 870876.[CrossRef][Medline]
Coghlan MJ, Carroll WA, and Gopalakrishnan M (2001) Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress. J Med Chem 44: 16271653.[CrossRef][Medline]
Cox DH and Aldrich RW (2000) Role of the beta1 subunit in large-conductance Ca(2+)-activated K(+) channel gating energetics. Mechanisms of enhanced Ca(2+) sensitivity. J Gen Physiol 116: 411432.
Dick GM, Rossow CF, Smirnov S, Horowitz B, and Sanders KM (2001) Tamoxifen activates smooth muscle BK channels through the regulatory
1 subunit. J Biol Chem 276: 3459434599.
Fernández-Fernández JM, Tomas M, Vazquez E, Orio P, Latorre R, Senti M, Marrugat J, and Valverde MA (2004) Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension. J Clin Investig 113: 10321039.[CrossRef][Medline]
Fukao M, Mason HS, Kenyon JL, Horowitz B, and Keef KD (2001) Regulation of BKCa channels expressed in human embryonic kidney 293 cells by epoxyeicosatrienoic acid. Mol Pharmacol 59: 1623.
Giangiacomo KM, Kamassah A, Harris G, and McManus OB (1998) Mechanism of maxi-K channel activation by dehydrosoyasaponin-I. J Gen Physiol 112: 485501.
Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, et al. (2001) Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med 7: 471477.[CrossRef][Medline]
Holland M, Langton PD, Standen NB, and Boyle JP (1996) Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle. Br J Pharmacol 117: 119129.[Medline]
Imaizumi Y, Muraki K, and Watanabe M (1989) Ionic currents in single smooth muscle cells from the ureter of the guinea-pig. J Physiol (Lond) 411: 131159.
Imaizumi Y, Ohi Y, Yamamura H, Ohya S, Muraki K, and Watanabe M (1999) Ca2+ spark as a regulator of ion channel activity. Jpn J Pharmacol 80: 18.[CrossRef][Medline]
Imaizumi Y, Sakamoto K, Yamada A, Hotta A, Ohya S, Muraki K, Uchiyama M, and Ohwada T (2002) Molecular basis of pimarane compounds as novel activators of large-conductance Ca2+-activated K+ channel
-subunit. Mol Pharmacol 62: 836846.
Imaizumi Y, Torii Y, Ohi Y, Nagano N, Atsuki K, Yamamura H, Muraki K, Watanabe M, and Bolton TB (1998) Ca2+ images and K+ current during depolarization in smooth muscle cells of the guinea-pig vas deferens and urinary bladder. J Physiol (Lond) 510: 705719.
Kaczorowski GJ and Garcia ML (1999) Pharmacology of voltage-gated and calcium-activated potassium channels. Curr Opin Chem Biol 3: 448458.[CrossRef][Medline]
Lawson K (2000) Potassium channel openers as potential therapeutic weapons in ion channel disease. Kidney Int 57: 838845.[CrossRef][Medline]
Lee SH, Hensens OD, Helms GL, Liesch JM, Zink DL, Giacobbe RA, Bills GF, Stevens-Miles S, Garcia ML, and Schmalhofer WA (1995) L-735,334, a novel sesquiterpenoid potassium channel-agonist from Trichoderma virens. J Nat Prod 58: 18221828.[Medline]
McManus OB, Harris GH, Giangiacomo KM, Feigebaum P, Reuben JP, Addy ME, Burka JF, Kaczorowski GJ, and Garcia ML (1993) An activator of calcium-dependent potassium channels isolated from a medicinal herb. Biochemistry 32: 61286133.[CrossRef][Medline]
McManus OB, Helms LM, Pallanck L, Ganetzky B, Swanson R, and Leonard RJ (1995) Functional role of the beta subunit of high conductance calcium-activated potassium channels. Neuron 14: 645650.[CrossRef][Medline]
Murakami M, Yamamura H, Suzuki T, Kang M, Ohya S, Murakami A, Miyoshi I, Sasano H, Muraki K, Hano T, et al. (2003) Modified cardiovascular L-type channels in mice lacking the voltage-dependent Ca2+ channel
3 subunit. J Biol Chem 278: 4326143267.
Nelson MT and Quayle JM (1995) Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268: C799C822.[Medline]
Ohi Y, Yamamura H, Nagano N, Ohya S, Muraki K, Watanabe M, and Imaizumi Y (2001) Local Ca2+ transients and distribution of BK channels and ryanodine receptors in smooth muscle cells of guinea-pig vas deferens and urinary bladder. J Physiol (Lond) 534: 313326.
Ohwada T, Nonomura T, Maki K, Sakamoto K, Ohya S, Muraki K, and Imaizumi Y (2003) Dehydroabietic acid derivatives as a novel scaffold for large-conductance calcium-activated K+ channel openers. Bioorg Med Chem Lett 13: 39713974.[CrossRef][Medline]
Ottolia M and Toro L (1994) Potentiation of large conductance KCa channels by niflumic, flufenamic and mefenamic acids. Biophys J 67: 22722279.[Medline]
Schrøder RL, Strobaek D, Olesen SP, and Christophersen P (2003) Voltage-independent KCNQ4 currents induced by (±)BMS-204352. Pflueg Arch Eur J Physiol 446: 607616.[CrossRef][Medline]
Singh SB, Goetz MA, Zink DL, Dombrowski AW, Polishook JD, Garcia ML, Schmalhofer W, McManus OB, and Kaczorowski GJ (1994) Maxikdiol: a novel dihydroxyisoprimane as an agonist of maxi-K channels. J Chem Soc Perkin Trans 1: 33493352.
Uebele VN, Lagrutta A, Wade T, Figueroa DJ, Liu Y, McKenna E, Austin CP, Bennett PB, and Swanson R (2000) Cloning and functional expression of two families of beta-subunits of the large conductance calcium-activated K+ channel. J Biol Chem 275: 2321123218.
Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI, Mann GE, Vergara C, and Latorre R (1999) Acute activation of maxi-K channels (hSlo) by estradiol binding to the
subunit. Science (Wash DC) 285: 19291931.
Vergara C, Latorre R, Marrion NV, and Adelman JP (1998) Calcium-activated potassium channels. Curr Opin Neurobiol 8: 321329.[CrossRef][Medline]
Wallner M, Meera P, and Toro L (1996) Determinant for
-subunit regulation in high-conductance voltage-activated and Ca2+-sensitive K+ channels: an additional transmembrane region at the N terminus. Proc Natl Acad Sci USA 93: 1492214927.
Wellman GC and Nelson MT (2003) Signaling between SR and plasmalemma in smooth muscle: sparks and the activation of Ca2+ sensitive ion channels. Cell Calcium 34: 211229.[CrossRef][Medline]
Yamada A, Gaja N, Ohya S, Muraki K, Narita H, Ohwada T, and Imaizumi Y (2001) Usefulness and limitation of DiBAC4(3), a voltage-sensitive fluorescent dye, for the measurement of membrane potentials regulated by recombinant large conductance Ca2+-activated K+ channels in HEK293 cells. Jpn J Pharmacol 86: 342350.[CrossRef][Medline]
Yamamura H, Nagano N, Hirano M, Muraki K, Watanabe M, and Imaizumi Y (1999) Activation of Ca2+-dependent K+ current by nordihydroguaiaretic acid in porcine coronary arterial smooth muscle cells. J Pharmacol Exp Ther 291: 140146.
Yellen G (1984) Ionic permeation and blockade in Ca2+-activated K+ channels of bovine chromaffin cells. J Gen Physiol 84: 157186.
This article has been cited by other articles:
![]() |
X.-H. Sun, J.-P. Ding, H. Li, N. Pan, L. Gan, X.-L. Yang, and H.-B. Xu Activation of Large-Conductance Calcium-Activated Potassium Channels by Puerarin: The Underlying Mechanism of Puerarin-Mediated Vasodilation J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 391 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Bentzen, A. Nardi, K. Calloe, L. S. Madsen, S.-P. Olesen, and M. Grunnet The Small Molecule NS11021 Is a Potent and Specific Activator of Ca2+-Activated Big-Conductance K+ Channels Mol. Pharmacol., October 1, 2007; 72(4): 1033 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Morimoto, K. Sakamoto, H. Sade, S. Ohya, K. Muraki, and Y. Imaizumi Voltage-Sensitive Oxonol Dyes Are Novel Large-Conductance Ca2+-Activated K+ Channel Activators Selective for beta1 and beta4 but Not for beta2 Subunits Mol. Pharmacol., April 1, 2007; 71(4): 1075 - 1088. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||